Healing cancer with immune cells – the miracle therapy becomes possible for everyone

Frankfurt Emily Whitehead has celebrated her birthday twice a year for the past ten years. Once for the anniversary of her birth and once because she is another year cancer free. The young American was saved by the so-called CAR-T therapy. The patient’s immune cells are reprogrammed in such a way that they successfully fight the aggressive blood cancer cells.

The procedure is a milestone in medical history. The CAR-T therapy from the Swiss pharmaceutical company Novartis was approved for the first time in the USA in 2017. In the meantime, countless previously terminally ill blood cancer patients owe their lives to innovative cell therapies.

But there could be many more human lives. Therapies such as those for Emily Whitehead are still largely produced in a clean room, which is expensive. This is time-consuming and makes them expensive – the costs are more than a quarter of a million euros.

Emily Whitehead

In 2012, the pediatric cancer doctor Stephan Grupp examined the then six-year-old American, who was the first child to receive CAR-T therapy and thus defeated the blood cancer and today, more than ten years later, has not yet had a relapse.

(Photo: AP)

Read on now

Get access to this and every other article in the

Web and in our app free of charge for 4 weeks.

Further

Read on now

Get access to this and every other article in the

web and in our app.

Further

source site-12